top of page
Multiplo® Product Line - A Simple Solution in One
MedMira's unique Multiplo® Product Line: Did you know, MedMira is working with a number of cruise lines which offer MedMira's Multiplo®...
MedMira
Jun 30, 20221 min read
MedMira Receives Patent for its Unique Quantitative Diagnostic System
Halifax, Nova Scotia, June 6, 2022 – Today, MedMira Inc. (MedMira) (TSXV: MIR) announces the receipt of a U.S. patent (number 11,353,450)...
MedMira
Jun 5, 20224 min read
Update on the new In Vitro Diagnostic Medical Devices Regulation (IVDR) in the European Market
Halifax, Nova Scotia, 27 May, 2022 – Today, MedMira Inc. (MedMira) (TSXV: MIR) provides an update on its regulatory progress in Europe...
MedMira
May 26, 20222 min read
VYRA™ Product Line Update
Halifax, Nova Scotia, 20 May, 2022 – Today, MedMira Inc. (MedMira) (TSXV: MIR) provides an update on the Company’s regulatory work for...
MedMira
May 19, 20222 min read
Test yourself in a smart way
A fact sheet for the importance of testing for both TP/nTP. Multiplo Compete Syphilis (TP/nTP) Antibody Test - testing was never so easy...
MedMira
May 17, 20221 min read
MedMira receives CE mark for Multiplo® Complete Syphilis (TP/nTP) Antibody Test
Halifax, Nova Scotia, 12 May, 2022 – Today, MedMira Inc. (MedMira) (TSXV: MIR) announces the achievement of another milestone in its...
MedMira
May 11, 20222 min read
bottom of page